Dr. Lipner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
410 Market St Suite 400A
Chapel Hill, NC 27516
Summary
- I am a dermatology resident physician at the University of North Carolina (UNC) and a graduate of the UNC MD-PhD Program with a PhD in Pharmacology. My research equipped me with the skills to solve practical problems, critically analyze scientific literature, and maintain productivity in stressful situations, while my clinical experiences have prepared me to build a practice consisting of medical, surgical, cosmetic, and laser dermatology in both adult and pediatric populations.
When not busy at work or studying, my time can seem even busier as my wife and I keep up with our two young daughters and dog - and I wouldn’t want it any other way! We cherish our time spent together outdoors, trying our hand at recipes from around the world, and watching football in the fall.
Clinical Expertise
- General dermatology, Pediatric dermatology, Skin cancer, Dermatology, Pharmacology, Procedural and cosmetic dermatology
Education & Training
- University of North Carolina HospitalsResidency, Dermatology, 2021 - 2025
- HCA Healthcare/Mercer University School of Medicine/Grand Strand Medical CenterInternship, Internal Medicine, 2021 - 2022
- University of North Carolina at Chapel Hill School of MedicineClass of 2021, MD-PhD
Certifications & Licensure
- NH State Medical License 2024 - 2026
- NC State Medical License 2022 - 2025
- SC State Medical License 2021 - 2022
Publications & Presentations
PubMed
- 86 citationsHeart dosimetric analysis of three types of cardiac toxicity in patients treated on dose-escalation trials for Stage III non-small-cell lung cancerKyle Wang, Kevin A. Pearlstein, Nicholas D. Patchett, Allison M. Deal, Panayiotis Mavroidis
Radiotherapy and Oncology. 2017-11-01 - 283 citationsCardiac Toxicity After Radiotherapy for Stage III Non-Small-Cell Lung Cancer: Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 Gy.Kyle Wang, Michael J. Eblan, Allison M. Deal, Matthew B. Lipner, Timothy M. Zagar
Journal of Clinical Oncology. 2017-01-23 - 21 citationsIrreversible JNK1-JUN inhibition by JNK-IN-8 sensitizes pancreatic cancer to 5-FU/FOLFOX chemotherapyMatthew B. Lipner, Xianlu L. Peng, Chong Jin, Yi Xu, Yanzhe Gao
JCI Insight. 2020-04-23
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: